Home -> Law Blog Directory -> Intellectual Property Law Blogs -> Orange Book Blog: At the Intersection of Patent Law and FDA Law

Intellectual Property Law

: Orange Book Blog: At the Intersection of Patent Law and FDA Law

C5 "Biotech Patenting" Conference, London, September 23-24

By Aaron Barkoff

C5 will be bringing its popular "Biotech Patenting" conference to London on September 23-24.

According to C5, the conference "provides updates on the latest developments in biotech patenting, including recent case law and regulatory developments."  The conference is unique in offering an international perspective on biotechnology patent law:  experts from Europe, Asia and the United States will be speaking.  One of the highlights will be a keynote address by Judge Randall Rader of the U.S. Court of Appeals for the Federal Circuit.

The agenda includes numerous talks and panel discussions that should be of interest to Orange Book Blog readers, such as:

• "Critical Update on Legislative and Policy Developments at the UK-IPO and EPO," presented by officials from the UK-IPO and the EPO
• "Review of Recent EPO and EU National Court Biotech Decisions"
• "Impact of the EPC 2000 on Medical Use Claims"
• "Analysis of the Latest Decisions of the U.S. Courts and Their Implications"
• "Obviousness Determinations After KSR v. Teleflex"
• "How to Successfully Obtain and Enforce Your Biotech Patents in China and India"
• "Comparison of the U.S. and European Legal Issues Surrounding Biosimilars:  Legislation, Case Law and Approvals to Date"
• "Managing Your Biotech Patent Litigation: In-House and Outside Counsel Perspectives"

In addition, two pre-conference workshops are offered on September 22:  "How to Conduct Effective IP Due Diligence" and "Successfully Evaluating Freedom to Operate."

Orange Book Blog readers can receive a 10% discount off the registration fee with the following code:  789L09.OBB.

For more information or to register, please visit the conference website.

Full post as published by Orange Book Blog: At the Intersection of Patent Law and FDA Law on July 18, 2008 (boomark / email).